Cargando…
Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan
Information about Parkinson’s disease (PD) patients with severe COVID-19 is scarce. We aimed to analyze the clinical characteristics, outcomes, and risk factors affecting the prognosis of PD patients with severe COVID-19 infection. Clinical data of severe COVID-19 patients admitted at the Union Hosp...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779096/ https://www.ncbi.nlm.nih.gov/pubmed/33392827 http://dx.doi.org/10.1007/s00702-020-02283-y |
_version_ | 1783631263447384064 |
---|---|
author | Zhai, Heng Lv, Yinzhang Xu, Yu Wu, Yi Zeng, Weiqi Wang, Tao Cao, Xuebing Xu, Yan |
author_facet | Zhai, Heng Lv, Yinzhang Xu, Yu Wu, Yi Zeng, Weiqi Wang, Tao Cao, Xuebing Xu, Yan |
author_sort | Zhai, Heng |
collection | PubMed |
description | Information about Parkinson’s disease (PD) patients with severe COVID-19 is scarce. We aimed to analyze the clinical characteristics, outcomes, and risk factors affecting the prognosis of PD patients with severe COVID-19 infection. Clinical data of severe COVID-19 patients admitted at the Union Hospital, Wuhan between 28th January and 29th February 2020 were collected and analyzed. 10 patients (1.96%) had a medical history of PD with a mean (SD) age of 72.10 (± 11.46) years. The clinical characteristics and outcomes of severe COVID-19 with and without PD patients were then compared. There was no significant difference in overall mortality between the PD and non-PD patients with severe COVID-19 (p > 0.05). In PD patients with severe COVID-19, the proportion of patients with critical type, disturbance of consciousness, incidence of complications, white blood cells count and neutrophils counts on admission seem higher in the non-survivors. PD patients with older age, longer PD duration, and late stage PD may be highly susceptible to critical COVID-19 infection and bad outcome. The PD patients with consciousness disorders and complications that progressed rapidly are at increased risk of death. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00702-020-02283-y. |
format | Online Article Text |
id | pubmed-7779096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-77790962021-01-04 Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan Zhai, Heng Lv, Yinzhang Xu, Yu Wu, Yi Zeng, Weiqi Wang, Tao Cao, Xuebing Xu, Yan J Neural Transm (Vienna) Neurology and Preclinical Neurological Studies - Original Article Information about Parkinson’s disease (PD) patients with severe COVID-19 is scarce. We aimed to analyze the clinical characteristics, outcomes, and risk factors affecting the prognosis of PD patients with severe COVID-19 infection. Clinical data of severe COVID-19 patients admitted at the Union Hospital, Wuhan between 28th January and 29th February 2020 were collected and analyzed. 10 patients (1.96%) had a medical history of PD with a mean (SD) age of 72.10 (± 11.46) years. The clinical characteristics and outcomes of severe COVID-19 with and without PD patients were then compared. There was no significant difference in overall mortality between the PD and non-PD patients with severe COVID-19 (p > 0.05). In PD patients with severe COVID-19, the proportion of patients with critical type, disturbance of consciousness, incidence of complications, white blood cells count and neutrophils counts on admission seem higher in the non-survivors. PD patients with older age, longer PD duration, and late stage PD may be highly susceptible to critical COVID-19 infection and bad outcome. The PD patients with consciousness disorders and complications that progressed rapidly are at increased risk of death. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00702-020-02283-y. Springer Vienna 2021-01-03 2021 /pmc/articles/PMC7779096/ /pubmed/33392827 http://dx.doi.org/10.1007/s00702-020-02283-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Neurology and Preclinical Neurological Studies - Original Article Zhai, Heng Lv, Yinzhang Xu, Yu Wu, Yi Zeng, Weiqi Wang, Tao Cao, Xuebing Xu, Yan Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan |
title | Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan |
title_full | Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan |
title_fullStr | Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan |
title_full_unstemmed | Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan |
title_short | Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan |
title_sort | characteristic of parkinson’s disease with severe covid-19: a study of 10 cases from wuhan |
topic | Neurology and Preclinical Neurological Studies - Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779096/ https://www.ncbi.nlm.nih.gov/pubmed/33392827 http://dx.doi.org/10.1007/s00702-020-02283-y |
work_keys_str_mv | AT zhaiheng characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan AT lvyinzhang characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan AT xuyu characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan AT wuyi characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan AT zengweiqi characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan AT wangtao characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan AT caoxuebing characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan AT xuyan characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan |